Factors associated with good patient outcomes following convalescent plasma in COVID-19: a prospective phase II clinical trial

D Ibrahim, L Dulipsingh, L Zapatka, R Eadie… - Infectious diseases and …, 2020 - Springer
… for COVID-19 exists. We conducted a prospective single-arm open-label phase II clinical
trial … the safety and efficacy of convalescent plasma in hospitalized patients with COVID-19. …

Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I–II trial

N Sanmamed, P Alcantara, S Gómez, A Bustos… - Radiotherapy and …, 2022 - Elsevier
… We conducted a prospective phase I–II trial enrolling COVID-19 patients ≥50 years-old,
with bilateral lung involvement at imaging study and oxygen requirement (oxygen saturation ≤…

[HTML][HTML] Severe COVID-19 in Uganda across two epidemic phases: a prospective cohort study

…, B Kikaire, JJ Lutwama, LC of COVID - The American journal …, 2021 - ncbi.nlm.nih.gov
… Among a prospective cohort of children and adults admitted to a national COVID-19
Across two epidemic phases differentiated by varying levels of community transmission, the …

Clinical features and prognostic factors in Covid-19: a prospective cohort study

S de Bruin, LD Bos, MA van Roon, AM Tuip-de Boer… - …, 2021 - thelancet.com
… We performed a prospective cohort study of patients with COVID-19 admitted to general …
biomarkers in potential important pathways of COVID-19 infection (inflammation, tissue damage, …

Inactivated whole-virus vaccine triggers low response against SARS-CoV-2 infection among renal transplant patients: prospective phase 4 study results

J Medina-Pestana, DT Covas, LA Viana… - …, 2022 - journals.lww.com
… Furthermore, we analyzed the clinical effectiveness of the vaccine comparing the COVID-19
incidence and outcomes of fully vaccinated kidney transplant recipients versus a control …

Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19

M Imran, M Kumar Arora, SMB Asdaq, SA Khan… - Molecules, 2021 - mdpi.com
COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phase 3 clinical trial against
COVID-19. … is to enlighten the researchers working on COVID-19 about the discovery, recent …

COVID-19 Vaccines Safety Tracking (CoVaST): protocol of a multi-center prospective cohort study for active surveillance of COVID-19 vaccines' side effects

A Riad, H Schünemann, S Attia, TP Peričić… - International journal of …, 2021 - mdpi.com
… -country, three-phase study including a cross-sectional survey to test for the short-term side
effects of COVID-19 vaccines among target population groups. In the second phase, we will …

COVID-19 myocarditis and prospective heart failure burden

A Shchendrygina, E Nagel, VO Puntmann… - Expert review of …, 2021 - Taylor & Francis
… We find ourselves, however, at the very beginning of the COVID-19 pandemic, and prospective
studies, which include larger number of recovered patients are needed to confirm this …

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort …

A Coppo, G Bellani, D Winterton, M Di Pierro… - The Lancet …, 2020 - thelancet.com
… During the review process of this Article, the use of awake prone positioning in patients with
COVID-19 was reported, suggesting a substantial improvement in oxygenation and a lack of …

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

ARYB Lee, SY Wong, LYA Chai, SC Lee, MX Lee… - Bmj, 2022 - bmj.com
… Systemic autoimmune myopathies: A prospective phase 4 controlled trial of an inactivated
virus vaccine against SARS-CoV-2. Rheumatology (Oxford) 2021; published online …